S1PR1 Mislocalization in Lung Endothelium Regulates Innate Immune Function and Mediates Inflammatory Lung Injury
S1PR1 在肺内皮细胞中的错误定位调节先天免疫功能并介导炎症性肺损伤
基本信息
- 批准号:10494616
- 负责人:
- 金额:$ 44.38万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-20 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:Acute Lung InjuryAddressAnti-Inflammatory AgentsBacterial InfectionsBindingBlood VesselsCalciumCell Differentiation processCell surfaceCellsChromatinDataDevelopmentEndoplasmic ReticulumEndothelial CellsEndotheliumEpigenetic ProcessEventG-Protein-Coupled ReceptorsGRP78 geneGTP-Binding Protein alpha Subunits, GsGTP-Binding ProteinsGasesGene-ModifiedGenesHomeostasisImmuneImmunoglobulin binding proteinsImmunoglobulinsImmunologic MarkersImmunologicsIndividualInfectionInflammationInflammatoryInjuryInnate Immune SystemInstructionKnock-inKnockout MiceLeukocytesLigationLungMediatingMediator of activation proteinMembraneModelingModificationMolecularMolecular ChaperonesMusMyeloid CellsPhenotypePhosphorylationPlayPositioning AttributePost-Translational Protein ProcessingProtein Tyrosine KinaseProteinsPseudomonasPseudomonas aeruginosaReceptor ActivationReceptor SignalingResolutionRoleSignal TransductionSiteSphingosine-1-Phosphate ReceptorSurfaceTNF geneTestingTissuesTyrosineVascular EndotheliumVirus Diseasesbasecellular imagingcytokineepigenomeimmune activationinnate immune functionlung imaginglung injurymouse modelmutant mouse modelnovelnovel markerpreventreceptorrecruittooltranscriptometwo-photonvascular injury
项目摘要
ABSTRACT
Uncontrolled accumulation of inflammatory cells in the airspace paired with vascular injury causes lethal acute
lung injury (ALI). The microvascular endothelium, with which immune cells are continuously in contact with, plays
a critical role in maintaining lung homeostasis basally and after infection. Sphingosine-1-phosphate receptor-1
(S1PR1), a G-protein coupled receptor (GPCR) expressed on the endothelial cell (EC) surface, is a well-known
mediator of “barrier protection” and “resolution of inflammation”. Here we have discovered that S1PR1 can also
trigger counterproductive signaling, thus changing the lung vascular niche. The focus of Project 1 is to identify
post-translationally modified S1PR1 as a significant molecular switch that epigenetically modifies EC from an
anti-inflammatory phenotype to an immune-active phenotype, leading to irreversible inflammatory lung injury.
Our Supporting Data show that: 1) inflammatory cytokines (e.g., TNFα) produced during inflammatory injury
phosphorylates S1PR1 on tyrosine143 (Y143-S1PR1); 2) Y143-phosphorylated S1PR1 in turn signaled receptor
translocation and localization to the endoplasmic reticulum (ER), 3) the chaperone protein BiP (Binding
immunoglobulin Protein) was essential for the translocation and binding of Y143-S1PR1 to the ER membrane, 4)
the ER-associated Y143-S1PR1 subsequently bound to the intracellular heteromeric GTP binding protein Gi, and
when activated by intracellular S1P augmented store-operated calcium entry (SOCE) in a Gi-dependent manner,
and 5) rendering S1PR1 constitutively phosphorylated (by editing Y143 to D143) in EC of mice increased lung
inflammatory injury. Lung EC also gained epigenetic modifications of genes inducing vascular development and
myeloid cells differentiation and activation following injury by Pseudomonas aeruginosa, suggesting injury-
specific modulation of EC epigenome. Based on these provocative data, Project 1 will test the hypothesis that
ER-resident Y143-S1PR1 is a crucial point of confluence for key signaling events with the potential to rewire the
EC epigenome, shifting EC into an inflammatory phenotype leading to intractable lung injury. Our Specific Aims
are: Aim #1: to address the role of Y143 phosphorylation of S1PR1 in the ER positioning of S1PR1 and
reprogramming of lung endothelium, and thereby leading to inflammatory lung injury; and Aim #2: to study the
role of chaperone protein BiP interaction with Y143 phosphorylated-S1PR1 in stabilizing S1PR1 at ER membrane
and mediating the shift to inflammatory phenotype in lung EC. We will use genetically modified mice generated
using Crisper-Cas9 gene editing as well as EC-specific S1PR1 null mice and tools available in Cores such as
epigenetic analysis (Core B), multichannel cellular imaging (Core C), and 2-photon imaging of lung EC and
immune cells in living mouse (Core C) to define mechanistically how ER-resident Y143-S1PR1 in EC centralizes
these signaling events to control the fate of immune cells in the lungs. We believe studies will identify novel
markers of the immunologically active endothelium and targets for preventing inflammatory lung injury through
manipulation of ER-S1PR1 and BiP signaling.
摘要
不受控制的炎症细胞积聚在空气中与血管损伤配对,导致致命的急性
肺损伤(ALI)。免疫细胞持续接触的微血管内皮,
在基础和感染后维持肺部稳态方面发挥关键作用。1-磷酸鞘氨醇受体-1
在内皮细胞(EC)表面上表达的G蛋白偶联受体(GPCR)(S1 PR 1)是公知的免疫调节剂。
介导“屏障保护”和“炎症消退”。在这里我们发现S1 PR 1也可以
触发适得其反的信号,从而改变肺血管生态位。项目1的重点是确定
作为一个重要的分子开关,后修饰的S1 PR 1表观遗传修饰EC,
抗炎表型转化为免疫活性表型,导致不可逆的炎性肺损伤。
我们的支持性数据显示:1)炎性细胞因子(例如,炎症损伤时产生的TNFα
磷酸化酪氨酸143上的S1 PR 1(Y143-S1 PR 1); 2)Y143-磷酸化的S1 PR 1进而信号传导受体
转运和定位到内质网(ER),3)伴侣蛋白BiP(结合
免疫球蛋白蛋白)对于Y143-S1 PR 1移位和结合到ER膜是必需的,4)
ER相关的Y143-S1 PR 1随后与细胞内异聚GTP结合蛋白Gi结合,和
当被细胞内S1 P以Gi依赖性方式激活时,
和5)使小鼠EC中的S1 PR 1组成性磷酸化(通过将Y143编辑为D143),增加肺
炎性损伤肺EC还获得了诱导血管发育的基因的表观遗传修饰,
铜绿假单胞菌损伤后骨髓细胞分化和活化,表明损伤-
EC表观基因组的特异性调节。基于这些令人激动的数据,项目1将检验以下假设:
ER驻留的Y143-S1 PR 1是关键信号事件的关键汇合点,具有重新连接细胞的潜力。
EC表观基因组,将EC转变为导致顽固性肺损伤的炎性表型。我们的具体目标
目的#1:阐明S1 PR 1的Y143磷酸化在S1 PR 1的ER定位中的作用,
肺内皮细胞重新编程,从而导致炎症性肺损伤;目标2:研究
伴侣蛋白BiP与Y143磷酸化S1 PR 1相互作用在稳定ER膜S1 PR 1中的作用
并介导肺EC向炎性表型的转变。我们将使用转基因小鼠
使用Crisper-Cas9基因编辑以及EC特异性S1 PR 1无效小鼠和Cores中可用的工具,
表观遗传学分析(核心B)、多通道细胞成像(核心C)和肺EC的双光子成像,
活小鼠中的免疫细胞(核心C),以确定EC中ER驻留的Y143-S1 PR 1如何集中在
这些信号事件来控制肺部免疫细胞的命运。我们相信研究会发现新的
免疫活性内皮细胞的标记物和通过以下途径预防炎性肺损伤的靶点
ER-S1 PR 1和BiP信号传导的操纵。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DOLLY MEHTA其他文献
DOLLY MEHTA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DOLLY MEHTA', 18)}}的其他基金
Targeting mechanisms activating ion-channel for preventing acute lung injury
激活离子通道的靶向机制预防急性肺损伤
- 批准号:
10659781 - 财政年份:2023
- 资助金额:
$ 44.38万 - 项目类别:
The Lung Endothelium as an Instructive Niche for the Innate Immune System during Vascular Injury
肺内皮细胞作为血管损伤期间先天免疫系统的指导性生态位
- 批准号:
10494611 - 财政年份:2022
- 资助金额:
$ 44.38万 - 项目类别:
S1PR1 Mislocalization in Lung Endothelium Regulates Innate Immune Function and Mediates Inflammatory Lung Injury
S1PR1 在肺内皮细胞中的错误定位调节先天免疫功能并介导炎症性肺损伤
- 批准号:
10706510 - 财政年份:2022
- 资助金额:
$ 44.38万 - 项目类别:
The Lung Endothelium as an Instructive Niche for the Innate Immune System during Vascular Injury
肺内皮细胞作为血管损伤期间先天免疫系统的指导性生态位
- 批准号:
10706498 - 财政年份:2022
- 资助金额:
$ 44.38万 - 项目类别:
CREB Instruction of Macrophage Fate and Lung fluid homeostasis
CREB对巨噬细胞命运和肺液稳态的指导
- 批准号:
10305990 - 财政年份:2021
- 资助金额:
$ 44.38万 - 项目类别:
CREB Programming of Alveolar Macrophage Population and Inflammatory Lung Injury
肺泡巨噬细胞群和炎症性肺损伤的 CREB 编程
- 批准号:
10491070 - 财政年份:2021
- 资助金额:
$ 44.38万 - 项目类别:
CREB Programming of Alveolar Macrophage Population and Inflammatory Lung Injury
肺泡巨噬细胞群和炎症性肺损伤的 CREB 编程
- 批准号:
10701930 - 财政年份:2021
- 资助金额:
$ 44.38万 - 项目类别:
CREB Instruction of Macrophage Fate and Lung fluid homeostasis
CREB对巨噬细胞命运和肺液稳态的指导
- 批准号:
10625859 - 财政年份:2021
- 资助金额:
$ 44.38万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 44.38万 - 项目类别:
Research Grant